"Product.Name","Date.Issued.Updated","Link"
"0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter",2016-08-05,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm515233.htm"
"50 Percent Magnesium Sulfate Injection, USP by Hospira: Recall - Presence Of Particulate Matter",2016-04-14,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm496149.htm"
"5 Percent Dextrose Injection USP in PAB Container by B. Braun Medical: Recall - Leakage and/or Particulate Matter",2016-03-29,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm493059.htm"
"0.9 Percent Sodium Chloride Solution for Irrigation by Baxter: Recall - Presence of Particulate Matter",2016-02-18,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm486748.htm"
"Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter",2016-08-03,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm514678.htm"
"Amikacin Sulfate Injection USP, 1 gram/4mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter",2016-03-10,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm490119.htm"
"Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems",2016-05-03,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm498823.htm"
"Baxter IV Solutions (Select Lots): Recall - Potential for Leaking Containers and Particulate Matter",2016-01-27,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm483215.htm"
"Baxter IV Solutions: Recall - Potential Presence of Particulate Matter",2016-01-05,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm479948.htm"
"BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries",2016-05-13,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm500910.htm"
"Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)",2016-05-02,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm498607.htm"
"Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Clinical Trial Results Find Increased Risk of Leg and Foot Amputations",2016-05-18,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm501565.htm"
"Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication -  Strengthened Kidney Warnings",2016-06-14,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm506554.htm"
"Cetylev (acetylcysteine) Effervescent Tablets for Oral Solution by Arbor Pharmaceuticals: Recall - Inadequate Seal of Blister Pack",2016-08-18,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm517287.htm"
"Chantix (varenicline) and Zyban (bupropion): Drug Safety Communication - Mental Health Side Effects Revised",2016-12-16,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm533517.htm"
"Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup",2016-01-13,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm481563.htm"
"Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure",2016-04-05,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm494252.htm"
"Direct-Acting Antivirals for Hepatitis C: Drug Safety Communication - Risk of Hepatitis B Reactivating",2016-10-04,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm523690.htm"
"Family Care Eye Wash by United Exchange Corp: Recall - Microbial Contamination",2016-09-08,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm519602.htm"
"Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects",2016-07-26,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm513065.htm"
"Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections",2016-05-12,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm500665.htm"
"Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories: Recall - Microbial Contamination",2016-09-07,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm519570.htm"
"Eye Drops: FDA Statement - Potential Risk of Loose Safety Seals",2016-03-15,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm490862.htm"
"Eyesaline Eyewash by Honeywell: Recall - Microbial Contamination",2016-08-22,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm517484.htm"
"Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy",2016-04-26,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm497656.htm"
"Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity",2016-03-05,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm489316.htm"
"General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women",2016-12-14,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm533195.htm"
"GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc: Recall - Detached Needles on Syringe",2016-09-09,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm519907.htm"
"HCG and Sermorelin by Talon Compounding Pharmacy: Recall - Lack of Sterility Assurance",2016-07-22,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm512729.htm"
"Human and Animal Sterile Drug Products by I.V. Specialty: FDA Alert - Lack of Sterility Assurance",2016-03-09,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm489958.htm"
"Hyoscyamine Sulfate 0.125mg by Virtus Pharmaceuticals: Recall -  Superpotent and Subpotent Test Results",2016-09-15,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm520868.htm"
"Lamotrigine Orally Disintegrating Tablet 200 mg by Impax: Recall - Incorrect Labeling of Blister Cards",2016-08-29,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm518486.htm"
"Licorice Coughing Liquid OTC Cough Syrup by Ma Ying Long Pharmaceutical Group: CDER Alert - Contains Unidentified Morphine",2016-01-16,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm482100.htm"
"Loperamide (Imodium): Drug Safety Communication - Serious Heart Problems With High Doses From Abuse and Misuse",2016-06-07,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm505303.htm"
"Magnesium Sulfate in Water for Injection by Hospira: Recall - Incorrect Barcode Labeling on the Primary Container",2016-01-06,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm480224.htm"
"Metformin-containing Drugs: Drug Safety Communication - Revised Warnings for Certain Patients With Reduced Kidney Function",2016-04-08,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm494829.htm"
"Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall - Super-potent Product",2016-02-17,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm486431.htm"
"Noxafil (posaconazole): Drug Safety Communication - Dosing Errors when Switching between Different Oral Formulations; Label Changes Approved",2016-01-04,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm479782.htm"
"Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions",2016-05-10,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm500123.htm"
"Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring Boxed Warning About Serious Risks and Death",2016-08-31,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm518710.htm"
"Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications",2016-03-22,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm491715.htm"
"Oral Liquid Docusate Sodium by PharmaTech : Recall -  Contaminated with B. Cepacia",2016-07-16,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm511528.htm"
"Over-the-Counter Antacid Products Containing Aspirin: FDA Drug Safety Communication - Serious Bleeding Risk",2016-06-06,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm505190.htm"
"Oxacillin for Injection, USP, 10g by Sagent: Recall - Iron Oxide Particulate Matter",2016-08-19,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm517409.htm"
"Liquid Drug and Dietary Supplement Products by PharmaTech: Recall - Risk of Product Contamination",2016-08-09,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm515625.htm"
"PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl): Recall - Presence of Glass Particulate Matter",2016-05-09,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm499794.htm"
"Pioglitazone-containing Medicines: Drug Safety Communication - Updated FDA Review, Increased Risk of Bladder Cancer",2016-12-12,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm532772.htm"
"Compounded Products by Reliable Drug Pharmacy: Recall - Potential for Mislabeling and Lack of Quality Assurance",2016-03-28,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm492677.htm"
"Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter",2016-04-26,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm497828.htm"
"Sodium Bicarbonate Injection, USP by Hospira: Recall - Particulate Matter",2016-03-21,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm491506.htm"
"Sterile Drug Products by Cantrell Drug Company: Recall - Lack of Sterility Assurance",2016-11-21,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm529791.htm"
"Sterile Drug Products by Medaus Pharmacy: FDA Alert - Lack of Sterility Assurance",2016-04-01,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm493871.htm"
"Sterile Drug Products from Pharmakon Pharmaceuticals: Recall - Lack of Sterility Assurance",2016-04-16,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm496448.htm"
"Syrspend SF and Syrspend SF Grape Suspending Agents by Fagron: FDA Alert - Microbial Contamination with Yeast",2016-02-10,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm485897.htm"
"Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement - Risks Associated With Abuse and Dependence",2016-10-25,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm526151.htm"
"Tri-Coast Pharmacy Sterile Products: Recall - Lack of Sterility Assurance",2016-11-21,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm530199.htm"
"Unexpired Sterile Human and Animal Compounded Products by Abbott's Compounding Pharmacy: Recall - Lack of Sterility Assurance",2016-01-16,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm482102.htm"
"Well Care Compounding Pharmacy Sterile Compounded Products: Recall - Lack Of Sterility Assurance",2016-05-18,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm501624.htm"
"Sterile Products by Wells Pharmacy Network: Recall - Concern for Lack of Sterility Assurance",2016-09-22,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm522103.htm"
"Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars",2016-06-02,"http://wayback.archive-it.org/7993/20170110235424/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm504736.htm"
"0.9 Percent Sodium Chloride Injection, USP (AUTO-C) by Baxter International: Recall - Potential For Leaking Containers, Particulate Matter and Missing Port",2015-07-31,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456793.htm"
"0.9 Percent Sodium Chloride Injection, USP, 50mL and 100mL by Baxter: Recall - Particulate Matter",2015-07-20,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm455421.htm"
"0.9 Percent Sodium Chloride Injection, USP, 250 mL by Hospira : Recall - Particulate Matter",2015-01-23,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm430941.htm"
"0.9 Percent Sodium Chloride Injection, USP, 250 mL VisIV Container by Hospira: Recall - Particulate Matter",2015-03-06,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm436871.htm"
"Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength",2015-10-15,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm467076.htm"
"Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) by Teva Parenteral Medicines: Recall - Particulate Matter",2015-07-27,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456114.htm"
"Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL): Recall - Particulate Matter",2015-05-05,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm445606.htm"
"Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall -  Potential Impact on Product Sterility",2015-02-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm435440.htm"
"Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery",2015-10-29,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm470010.htm"
"Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors",2015-09-22,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm463595.htm"
"Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical: FDA Statement - FDA Warns of Potential Contamination",2015-12-09,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm476514.htm"
"Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion",2015-07-30,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456569.htm"
"Bupivacaine HCl Injection by Hospira: Recall - Iron Oxide Particulate In Glass Vials",2015-04-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm444384.htm"
"Calcium Chloride Intravenous Infusion 10% w/v 10mL Prefilled Syringe by Mylan: Market Withdrawal - Difficulties in Administration",2015-07-14,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm454836.htm"
"Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction",2015-03-09,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm437415.htm"
"Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program",2015-11-19,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm462229.htm"
"Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects",2015-07-01,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm453379.htm"
"Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial by Heritage Pharmaceuticals: Recall - Lack of Sterility Assurance",2015-02-25,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm435616.htm"
"Compounded Multivitamins by Glades Drugs: Voluntary Recall - High Amounts of Vitamin D3 (Cholecalciferol)",2015-11-25,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm474599.htm"
"Compounded or Repackaged Drugs Stored in Becton-Dickinson Syringes: FDA Expands Warning",2015-09-08,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461597.htm"
"Compounded or Repackaged Drugs Stored in Becton-Dickinson (BD) 3 mL and 5 mL Syringes: FDA Alert - Do Not Use Unless There Is No Suitable Alternative",2015-08-18,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm458955.htm"
"Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes",2015-06-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm452595.htm"
"Downing Labs, LLC Sterile Compounded Products: Recall - Lack of Sterility Assurance",2015-10-21,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm468235.htm"
"DPP-4 Inhibitors for Type 2 Diabetes: Drug Safety Communication - May Cause Severe Joint Pain",2015-08-28,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm460238.htm"
"Drug Products Intended to be Sterile by Chen Shwezin Inc., dba Park Compounding Pharmacy: FDA Statement - Lack of Sterility Assurance",2015-10-03,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm465582.htm"
"Entacapone: Drug Safety Communication - FDA Review Found No Increased Cardiovascular Risks",2015-10-26,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm469162.htm"
"Feraheme (ferumoxytol): Drug Safety Communication – Warnings Strengthened and Prescribing Instructions Changed",2015-03-31,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm440479.htm"
"FLOW-i Anesthesia Systems by Maquet: Class I Recall - Dislodged Patient Cassette May Stop Patient Ventilation",2015-07-01,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm453524.htm"
"Flurbiprofen-Containing Topical Pain Medications: FDA Alert - Illnesses and Deaths in Pets Exposed to Prescription Topical Pain Medication",2015-04-17,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm443386.htm"
"Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use",2015-07-27,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456012.htm"
"Gilenya (fingolimod): Drug Safety Communication - FDA Warns About Cases of Rare Brain Infection",2015-08-04,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm457183.htm"
"Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of  Heart Rate When Used With Antiarrhythmic Drug Amiodarone",2015-03-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439662.htm"
"Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall - Potential Presence of Foreign Tablets Contamination",2015-07-31,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm456881.htm"
"Injectable Products by Mylan: Recall - Presence of Particulate Matter",2015-06-08,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm444517.htm"
"Intravenous (IV) Solutions (Select Lots) by Baxter: Recall - Potential Presence of Particulate Matter",2015-04-10,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm442091.htm"
"Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density",2015-09-10,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461876.htm"
"Iodine-containing Contrast Agents for Medical Imaging: Drug Safety Communication - Rare Cases of Underactive Thyroid in Infants",2015-11-17,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm472995.htm"
"Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies",2015-10-22,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm468720.htm"
"Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials",2015-02-11,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm433962.htm"
"Lactated Ringer's Irrigation, 3000mL by Hospira: Recall - Mold Contamination",2015-03-12,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm437818.htm"
"Magnesium Sulfate in 5 Percent Dextrose Injection by Hospira: Recall - Incorrect Barcode Labeling",2015-03-06,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm437113.htm"
"Medistat RX Sterile Drug Products: Recall - Possible Contamination",2015-09-10,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm461850.htm"
"Mucinex Fast-MAX Products: Recall - Incorrect Labeling",2015-04-22,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm444082.htm"
"Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke",2015-07-09,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm454141.htm"
"4mg Norepinephrine Bitartrate (16mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 8mg Norepinephrine Bitartrate (32mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag by Pharmedium: Recall - Discoloration",2015-12-31,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm479680.htm"
"Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement - Consumer Warning About Potential Health Risks",2015-03-19,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439014.htm"
"Picato (ingenol mebutate) Gel: Drug Safety Communication - FDA Warns of Severe Adverse Events, Requires Label Changes",2015-08-21,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm459311.htm"
"Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death",2015-11-06,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm471531.htm"
"Potiga (ezogabine): Drug Safety Communication - FDA Determines 2013 Labeling Adequate to Manage Risks of Retinal Abnormalities, Potential Vision Loss, and Skin Discoloration",2015-06-16,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm451181.htm"
"Products from Prescription Center Pharmacy in Fayetteville, N.C.: Recall - Lack of Sterility Assurance",2015-04-02,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm441001.htm"
"Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy",2015-01-09,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm429604.htm"
"Proglycem (diazoxide): Drug Safety Communication - Reports of Pulmonary Hypertension in Infants and Newborns",2015-07-16,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm455125.htm"
"Prolotherapy with Phenol by Hartley Medical: Recall - Non-sterility Concerns",2015-08-18,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm458832.htm"
"Refresh Lacri-Lube, Refresh P.M., FML 0.1 Percent and Blephamide 10 Percent/0.2 Percent by Allergan: Recall - Particulate Matter",2015-08-25,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm459496.htm"
"Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)",2015-12-16,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm477601.htm"
"SGLT2 Inhibitors: Drug Safety Communication - Labels to Include Warnings About Too Much Acid in the Blood and Serious Urinary Tract Infections",2015-12-04,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm475553.htm"
"SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood",2015-05-15,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm446994.htm"
"Simulated IV Solutions from Wallcur: CDER Statement- FDA's Investigation into Patients being Injected",2015-01-14,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm430360.htm"
"Sterile Human and Veterinary Compounded Drugs by Moses Lake Professional Pharmacy: Recall - Lack of Sterility Assurance",2015-07-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm455931.htm"
"Testosterone Products: Drug Safety Communication - FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke",2015-05-15,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm436280.htm"
"Tramadol: Drug Safety Communication - FDA Evaluating Risks of Using in Children Aged 17 and Younger",2015-09-21,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm463499.htm"
"Treanda (bendamustine hydrochloride) Solution by Teva: FDA Statement - Not Compatible with Closed System Transfer Devices, Adapters, and Syringes Containing Polycarbonate or Acrylonitrile-Butadiene-Styrene",2015-09-04,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm437626.htm"
"Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality",2015-07-01,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm453430.htm"
"Sterile Compounded Products by US Compounding, Inc: Recall - Lack of Sterility Assurance",2015-09-24,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm464086.htm"
"Hepatitis C Treatments Viekira Pak and Technivie: Drug Safety Communication - Risk of Serious Liver Injury",2015-10-22,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm468757.htm"
"Virazole (Ribavirin Powder For Solution) by Valeant Pharmaceutical North America, LLC: Recall- Due to Microbial Contamination",2015-01-02,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm428700.htm"
"Zerbaxa (ceftolozane and tazobactam): Drug Safety Communication - FDA Cautions About Dose Confusion and Medication Errors",2015-05-20,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm447629.htm"
"Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication - FDA Review of Study Sheds Light on Two Deaths Associated with the Injectable Schizophrenia Drug",2015-03-23,"http://wayback.archive-it.org/7993/20170111132847/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm439472.htm"
"Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing",2014-01-14,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm381650.htm"
"Acetylcysteine Solution 10 Percent/Roxane: Recall - Glass Particles in Product",2014-02-15,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm386133.htm"
"Assured Brand Naproxen Sodium Tablets by Contract Packaging Resources, Inc.: Recall - Packaging Mix-Up",2014-10-22,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm419769.htm"
"Bo Ying Compound by Eu Yan Sang (Hong Kong) Ltd: FDA/CDER Statement  - Risk of Lead Poisoning",2014-09-26,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm416441.htm"
"Alli (60 mg orlistat capsules) by GlaxoSmithKline: Recall - Product Tampering",2014-03-28,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm391013.htm"
"Baxter IV Sodium Chloride and Potassium Chloride Solutions: Recall - Particulate Matter",2014-07-18,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm405786.htm"
"Calcium gluconate 10 percent Injections by Rx Formulations: Recall -  Microbial Contamination",2014-02-07,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm385125.htm"
"Captomer and Captomer-250 by Thorne Research: FDA Warning - Potential Health Risks",2014-06-13,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm401081.htm"
"CLINIMIX and CLINIMIX E Injection/Baxter: Recall - Particulate Matter in Products",2014-01-06,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm380396.htm"
"CUBICIN (daptomycin for injection) by Cubist Pharmaceuticals: Recall - Presence of Particulate Matter",2014-04-18,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm394025.htm"
"CUBICIN (daptomycin for injection) 500 mg in 10 mL Single Use Vials: Recall - Foreign Particulate Matter",2014-08-09,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm408934.htm"
"Coumadin (warfarin sodium) for Injection by Bristol-Myers Squibb: Recall - Particulate Matter",2014-07-01,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm403583.htm"
"Cubicin (daptomycin for injection) 500 mg in 10 mL Single Use Vials: Recall - Presence Of Particulate Matter",2014-08-07,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm408677.htm"
"Dermatend Original and Dermatend Ultra: Recall - Safety Concerns",2014-09-02,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm412397.htm"
"Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5 Percent Dextrose 5000mL (Ambu-Flex II): Recall - Presence of Particulate Matter",2014-08-15,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm410307.htm"
"DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5 Percent Dextrose 6000mL: Recall - Contamination With Mold",2014-03-06,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm388323.htm"
"Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates",2014-05-15,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397449.htm"
"Docetaxel: Drug Safety Communication - May Cause Symptoms of Alcohol Intoxication",2014-06-20,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402106.htm"
"Doribax (doripenem): Drug Safety Communication - Risk When Used to Treat Pneumonia on Ventilated Patients",2014-03-06,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm388328.htm"
"Effexor XR 150 Mg Extended-Release Capsules (Pfizer) and Venlafaxine HCl 150 Mg Extended-Release Capsules (Greenstone): Recall - Possible Presence of Tikosyn Capsules",2014-03-07,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm388352.htm"
"Epidural Corticosteroid Injection: Drug Safety Communication -  Risk of Rare But Serious Neurologic Problems",2014-04-23,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm394530.htm"
"Eszopiclone Containing Sleep Aids: Drug Safety Communication - Can Cause Next-Day Impairment",2014-05-15,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397536.htm"
"Etomidate Injection/Pfizer-Mylan: Recall - Presence of Particulate Matter and/or Illegible and Missing Lot Number and/or Expiry Date",2014-02-20,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm386618.htm"
"Flawless Beauty and Skin Products: Recall - Unapproved Drugs",2014-04-30,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm395391.htm"
"Gabapentin Capsules, USP 300 mg, by Aurobindo Pharma USA: Recall - Complaints of Empty Capsules",2014-11-24,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm424519.htm"
"Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 mL by Hospira: Recall - Particulate Matter",2014-09-12,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm414212.htm"
"Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled Overpouch",2014-11-21,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm424276.htm"
"Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 ML, Flexible Containers: Recall (One Lot) - Mold Contamination",2014-07-11,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm404667.htm"
"Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall - Mislabeled Packaging",2014-07-21,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm406124.htm"
"IV Solutions from Wallcur of San Diego: CDER Statement - FDA Warns Health Care Professionals Not to Inject Patients",2015-04-08,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm428496.htm"
"Ketorolac Tromethamine Injection, USP, 30mg/ml by Sagent Pharmaceuticals: Recall - Incorrect Labeling",2014-10-06,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm417445.htm"
"L-citrulline by Medisca: Alert - Potentially Subpotent Product",2014-02-17,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm385978.htm"
"Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter",2014-10-17,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm419322.htm"
"Lidocaine Viscous: Drug Safety Communication - Boxed Warning Required - Should Not Be Used to Treat Teething Pain",2014-06-26,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402790.htm"
"Lidocaine HCI Injection, USP, 2 percent, by Hospira: Recall - Visible Particulates",2014-07-30,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm407249.htm"
"Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates",2014-04-18,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm394026.htm"
"LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage",2014-10-15,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm418887.htm"
"Long-term Antiplatelet Therapy: Safety Announcement - Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death",2014-11-16,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm423165.htm"
"Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free Vial: Recall - Visible Particulates",2014-06-18,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm401724.htm"
"Marcaine (Bupivacaine HCI Injection, USP) 0.25 percent, 10 ml, Single-Dose, Preservative-Free Vial: Recall - Visible Particulates",2014-04-22,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm394464.htm"
"Martin Avenue Pharmacy, Inc. Compounded Sterile Preparations: Recall - Lack of Assurance of Sterility",2014-09-02,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm412493.htm"
"Medical Supply Liquidators Injectable Vitamin Products With a ""Sunshine Labs"" Label: Warning - Products Not FDA Approved",2014-06-30,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm403435.htm"
"Mitoxantrone by Hospira: Recall - Confirmed Subpotency and Out-Of-Specification",2014-12-23,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm427967.htm"
"NaturaLyte Liquid Bicarbonate Concentrate: Recall - Potential Health Risk",2014-05-28,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm398553.htm"
"Olmesartan: Drug Safety Communication - FDA Review Finds Cardiovascular Risks for Diabetics Not Conclusive",2014-06-24,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402616.htm"
"Oregon Compounding Centers, Inc. Unexpired Sterile Products: Recall - Lack of Sterility Assurance",2014-10-10,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm418359.htm"
"Over-The-Counter Topical Acne Products: Drug Safety Communication - Rare But Serious Hypersensitivity Reactions",2014-06-25,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402722.htm"
"Pharmacy Creations Certain Products: Recall – Potential Non-Sterility",2014-09-06,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm413053.htm"
"Potassium Chloride Injection (Baxter): Recall - Shipping Carton Mislabeling",2014-09-17,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm414957.htm"
"Pleo Homeopathic Drug Products by Terra-Medica: Recall - Potential for Undeclared Penicillin",2014-03-20,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm390002.htm"
"Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin",2014-05-13,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397179.htm"
"Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates",2014-04-18,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm393904.htm"
"Revatio (sildenafil): Drug Safety Communication - FDA Clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension",2014-03-31,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm391152.htm"
"Rohto Eye Drops - Mentholatum: Recall - Sterility Control Review",2014-01-17,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm382097.htm"
"Saxagliptin (marketed as Onglyza and Kombiglyze XR): Drug Safety Communication - FDA to Review Heart Failure Risk",2014-02-11,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm385471.htm"
"Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose",2014-01-08,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm380833.htm"
"Testosterone Products: FDA/CDER Statement - Risk of Venous Blood Clots",2014-06-20,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402054.htm"
"0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter",2014-12-16,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm426996.htm"
"Sodium Chloride IV 0.9 Percent by Baxter: Recall - Particulate Matter",2014-08-13,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/ucm409962.htm"
"Soliris (eculizumab) Concentrated Solution for IV Infusion by Alexion: Recall - Visible Particulates",2014-06-02,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm399536.htm"
"Sterile Drug Products by Unique Pharmaceuticals Ltd.: Recall - Lack of Sterility Assurance",2014-07-11,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm404786.htm"
"Tecfidera (dimethyl fumarate) by Biogen Idec: Drug Safety Communication - Case of Rare Brain Infection PML Reported",2014-11-25,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm424752.htm"
"Testosterone Products: Drug Safety Communication - FDA Investigating Risk of Cardiovascular Events",2014-01-31,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm384225.htm"
"Vancomycin Hydrochloride for Injection USP, Equivalent to 1 Gram Vancomycin (Sterile Powder) by Hospira, Inc.: Recall - Uncontrolled Storage During Transit",2014-10-08,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm418065.htm"
"VPRIV (velaglucerase alfa for injection): Recall - Visible Particulate Matter",2014-03-14,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm389326.htm"
"Labetalol Hydrochloride Injection 100 MG/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira: Recall - Visible Particulates",2014-05-16,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397775.htm"
"Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): Drug Alert - Lack of Sterility Assurance",2014-09-09,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm405941.htm"
"Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events",2014-09-26,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm416408.htm"
"Ziprasidone (Marketed as Geodon and Generics): Drug Safety Communication - Rare But Potentially Fatal Skin Reactions",2014-12-11,"http://wayback.archive-it.org/7993/20170111132857/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm426624.htm"
"Hospira brand Lidocaine and Marcaine: Recall - Presence Of  Particulate",2013-10-21,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370783.htm"
"Abrams Royal Pharmacy Sterile Products - Recall - Lack of Sterility Assurance",2013-12-19,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm379383.htm"
"Acetaminophen: Drug Safety Communication - Association with Risk of Serious Skin Reactions",2013-08-01,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm363519.htm"
"Aidapak Services LLC, Select Repackaged Pharmaceuticals: Recall - Potential Incorrect Labeling",2013-08-17,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm365417.htm"
"Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results",2013-10-17,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371210.htm"
"Altaire Pharmaceuticals Carboxymethylcellulose Sodium 0.5 Percent Ophthalmic Solution Sold Under Wal-Mart, CVS, and Target Brands: Recall - Preservative May Not Be Effective Through Expiry",2013-09-08,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367598.htm"
"Aminosyn II 10 percent, Sulfite-Free (Hospira): Recall - Particulate Matter Noted in One Lot",2013-09-03,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367002.htm"
"Arzerra (ofatumumab) and Rituxan (rituximab): Drug Safety Communication - New Boxed Warning, Recommendations to Decrease Risk of Hepatitis B Reactivation",2013-09-25,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm369846.htm"
"All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance",2013-05-18,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm352949.htm"
"Sterile Products Compounded, Repackaged, and Distributed by ApothéCure: Recall - Sterility Assurance Concerns",2013-04-16,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm348170.htm"
"All Sterile Compounded Products by Nora Apothecary And Alternative Therapies: Recall - Lack of Sterility Assurance",2013-04-23,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm349112.htm"
"Lyophilized Products Compounded by NuVision Pharmacy: Recall - Sterility Assurance Concerns",2013-04-16,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm348156.htm"
"Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection",2013-03-20,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm344664.htm"
"Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms",2013-03-12,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm343350.htm"
"Balanced Solutions All Sterile Compounded Products: Recall - Lack of Sterility Assurance",2013-04-22,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm348848.htm"
"Baxter 5 Percent Dextrose Injection, USP And 0.9 Percent Sodium Chloride Injection, USP Intravenous (IV) Solutions: Recall - Particulate Matter In Solution",2013-12-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm379915.htm"
"Beacon Hill Medical Pharmacy/Rxtra Solutions: Recall - Lack of Sterility Assurance",2013-08-01,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm363460.htm"
"Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter",2013-08-02,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm363741.htm"
"Benztropine Mesylate Injection by Fresenius Kabi USA: Recall - Potential Presence Of Glass Particles",2013-07-02,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm359330.htm"
"Bupivacaine HCL Injection 0.25% (2.5 MG/ML) and Bupivacaine HCL 0.75% (7.5 MG/ML), 30 ML Single-Dose Vials by Hospira, Inc.: Recall- Presence of Particulate Matter",2013-09-13,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm368405.htm"
"Clinical Specialties Compounding Pharmacy Products: Recall - All Sterile Products Recalled Due To Lack of Sterility Assurance",2013-03-21,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm344831.htm"
"Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance",2013-05-17,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm352939.htm"
"The Compounding Shop: FDA News Release -  Lack of Sterility Assurance of Drug Products",2013-09-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm351326.htm"
"Diabetes Treatments: FDA Alerts of Illegal Sales - Undeclared Ingredients",2013-07-23,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm362046.htm"
"Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure",2013-09-23,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm369457.htm"
"Enteric Coated Aspirin 81 mg Tablets by Advance Pharmaceutical Inc.: Recall of One Lot - May Contain Acetaminophen 500 mg Tablets",2013-06-19,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm357924.htm"
"Estarylla (norgestimate and ethinyl estradiol): Recall - Report of Placebo Tablet Present in Row of Active Tablets",2013-07-05,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm359656.htm"
"Ferrous Sulfate Tablets, 325 mg Labeled as Rugby Natural Iron Supplement: Recall - Bottle May Contain Meclizine HCl 25 mg Tablets",2013-01-18,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm336137.htm"
"Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns",2013-04-11,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm347755.htm"
"Healthy Life Chemistry By Purity First B-50: FDA Health Risk Warning - Undeclared Ingredients",2013-07-26,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm362800.htm"
"Hydroxyethyl Starch Solutions: FDA Safety Communication - Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding",2013-06-24,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm358349.htm"
"Iclusig (Ponatinib): Drug Safety Communication - Increased Reports Of Serious Blood Clots In Arteries And Veins",2013-12-20,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370971.htm"
"Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas",2013-03-14,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm343805.htm"
"Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion",2013-05-06,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350817.htm"
"Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility",2013-01-28,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm337089.htm"
"Leiter's Compounding Pharmacy: Recall - Concerns of Sterility Assurance",2013-09-12,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm368206.htm"
"Lexiscan (regadenoson) and Adenoscan (adenosine): Drug Safety Communication - Rare but Serious Risk of Heart Attack and Death",2013-11-20,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm375981.htm"
"Lidocaine HCl Injection 2%, 5 ml Vial by Hospira: Recall - Presence of Particulate Matter",2013-12-24,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm379751.htm"
"Low Molecular Weight Heparins: Drug Safety Communication - Recommendations to Decrease Risk of Spinal Column Bleeding and Paralysis",2013-11-06,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm373918.htm"
"Magnesium Sulfate: Drug Safety Communication - Recommendation Against Prolonged Use in Pre-term Labor",2013-05-30,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm354603.htm"
"Magnesium Sulfate Injection by Fresenius Kabi USA: Recall - Glass Particles in Vials",2013-05-29,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm354329.htm"
"Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections",2013-06-13,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm353953.htm"
"Med Prep Consulting Inc. Compounded Products: Recall - Potential Mold Contamination",2013-03-18,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm344259.htm"
"Mefloquine Hydrochloride: Drug Safety Communication - Label Changes Due To Risk of Serious Psychiatric and Nerve Side Effects",2013-07-29,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm362887.htm"
"Meridian Medical Technologies Auto-Injectors: Extension of Expiration Dates",2013-11-22,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376453.htm"
"Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials",2013-05-21,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm353266.htm"
"Methylphenidate ADHD Medications: Drug Safety Communication - Risk of Long-lasting Erections",2013-12-17,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378876.htm"
"MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz: Recall - Particles Identified",2013-09-08,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367597.htm"
"Nitroglycerin in 5% Dextrose Injection by Baxter: Recall - Particulate Matter",2013-11-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376967.htm"
"Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems",2013-07-26,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm362672.htm"
"Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)",2013-07-03,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm359528.htm"
"Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance",2013-05-30,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm354614.htm"
"Omontys (peginesatide) Injection by Affymax and Takeda: Recall of All Lots -  Serious Hypersensitivity Reactions",2013-02-23,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm340895.htm"
"Onfi (clobazam): Drug Safety Communication - Risk of Serious Skin Reactions",2013-12-03,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm377340.htm"
"Over-the-Counter Topical Antiseptic Products: Drug Safety Communication - FDA Requests Label Changes and Single-Use Packaging to Decrease Risk of Infection",2013-11-13,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm374892.htm"
"Pallimed Solutions, Inc. Sterile Compound Products: Recall - Visible Particulates Observed",2013-03-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm345477.htm"
"Park Compounding Sterile Medication: Recall – Concerns of Sterility Assurance",2013-09-10,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367864.htm"
"Perrigo Acetaminophen Infant Suspension Liquid: Recall - Potential Defect with Co-packaged Oral Syringe",2013-11-02,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm373404.htm"
"Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution",2013-04-30,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350085.htm"
"Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration",2013-11-01,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm349847.htm"
"Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - Removal of Some Prescribing and Dispensing Restrictions",2013-11-25,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376683.htm"
"Samsca (Tolvaptan): Drug Safety Communication - FDA Limits Duration and Usage Due To Possible Liver Injury Leading to Organ Transplant or Death",2013-04-30,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350185.htm"
"Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury",2013-01-25,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm336669.htm"
"Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death",2013-02-26,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm341255.htm"
"Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter",2013-04-26,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm349622.htm"
"Sodium Chloride Injection, 0.9 percent, 1000 mL, Flexible Container: Recall - Brass Particulates",2013-04-01,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm346011.htm"
"Soliris (Eculizumab) Concentrated Solution for Intravenous Infusion by Alexion: Recall - Visible Particles",2013-12-16,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm378646.htm"
"Specialty Compounding Sterile Products: FDA Alert - Bacterial Infections",2013-08-10,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm364595.htm"
"Specialty Medicine Compounding Pharmacy Certain Unexpired Compounded Sterile Products: Recall - Particulate Matter Found in Vials",2013-10-21,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371563.htm"
"Tygacil (tigecycline): Drug Safety Communication - Increased Risk of Death",2013-09-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370170.htm"
"Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches",2013-05-06,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm350868.htm"
"Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected",2013-06-10,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm356050.htm"
"Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter",2013-02-16,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm340094.htm"
"Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets",2013-06-12,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm356519.htm"
"Wellness Pharmacy, Inc. Products: Recall - Laboratory Results Indicating Microbial Contamination",2013-08-27,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm366505.htm"
"Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses",2013-05-14,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm334738.htm"
"Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication - FDA Investigating Two Deaths Following Injection",2013-06-18,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm357601.htm"
"University Compounding Pharmacy Injection Products: Recall - Lack of Sterility Assurance",2013-09-08,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367596.htm"
"Avella Specialty Pharmacy Sterile Medications:  Recall - Concerns Of Sterility Assurance At Testing Vendor",2013-09-09,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm367719.htm"
"Metoclopramide Injection And Ondansetron Injection by Hospira: Recall - Glass Strand Particulates Caused By Glass Supplier",2013-10-02,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm370663.htm"
"Cefepime For Injection, USP And Dextrose Injection, USP By B. Braun Medical Inc.: Recall - Visible Particulate Matter",2013-10-08,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371031.htm"
"Nature's Pharmacy and Compounding Center Sterile Compounded Products:  Recall - Lack of Sterility Assurance",2013-11-16,"http://wayback.archive-it.org/7993/20170111132858/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm375412.htm"
"Acetylcysteine Solution, USP (Roxane Laboratories, Inc.): Recall - Visible Glass Particle",2012-02-03,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm290219.htm"
"Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity",2012-01-13,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm287710.htm"
"Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication",2012-04-20,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm301120.htm"
"Ampyra (dalfampridine): Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients",2012-07-23,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm313055.htm"
"Altuzan (bevacizumab): Counterfeit Product - Contains no Active Ingredient",2012-04-03,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm298583.htm"
"American Regent Injectable Products: Recall - Visible Particulates in Products 					[ARCHIVED]",2012-02-23,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm242365.htm"
"Ameridose, LLC: Recall of Unexpired Products in Circulation",2012-10-31,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm326370.htm"
"Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates",2012-03-23,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm297100.htm"
"Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance",2012-11-28,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm329955.htm"
"Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices",2012-02-14,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm291968.htm"
"Bedford Laboratories Polymyxin B For Injection USP And Vecuronium Bromide For Injection: Recall - Glass Particles",2012-01-12,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm287411.htm"
"Benzalkonium Chloride Antiseptic Wipes by Dukal: Recall - Potential Microbial Contamination",2012-08-01,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm314006.htm"
"Brilliant Blue G Compounded by Franck's: Recall of Unapproved Drug - Ongoing Investigation of Fungal Endophthalmitis Cases",2012-04-20,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm296383.htm"
"Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified",2012-12-15,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332358.htm"
"CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure 					[ARCHIVED]",2012-01-12,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm263157.htm"
"Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms",2012-03-28,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm297624.htm"
"Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians",2012-05-04,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm301137.htm"
"Chantix (Varenicline): Safety Communication - Updated Safety Review On The Risk of Cardiovascular Adverse Events",2012-12-12,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm331626.htm"
"Codeine Use in Certain Children After Tonsillectomy and/or Adenoidectomy: Drug Safety Communication - Risk of Rare, But Life-Threatening Adverse Events or Death",2013-02-20,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315627.htm"
"Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility",2012-02-23,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm293132.htm"
"Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory -  Potential Safety Risk",2012-01-09,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm286280.htm"
"Franck’s Compounding Pharmacy Sterile Preparations: Reports of Fungal Endophthalmitis, Expanded Recall",2012-05-24,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm"
"Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose 					[ARCHIVED]",2012-05-14,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm284355.htm"
"Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up",2012-02-03,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm290295.htm"
"H & P Industries Povidone Iodine Prep Pads: Recall - Potential Microbial Contamination 					[ARCHIVED]",2012-02-08,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm247743.htm"
"Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength",2012-12-06,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm331168.htm"
"Hospira Carpuject Pre-filled Cartridges - Drug Alert: Products May Contain More Than the Intended Fill Volume",2012-05-23,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305236.htm"
"Hospira Hydromorphone Hydrochloride Injection 2 MG/ML, 1 mL fill in 2.5 mL Carpuject: Recall- May Contain More Than The Intended Fill Volume",2012-08-16,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm315685.htm"
"Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials",2012-07-16,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm312048.htm"
"Hospira Lactated Ringer's And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination",2012-10-06,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm322966.htm"
"Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets",2012-09-24,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm320610.htm"
"Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume",2012-05-14,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm304044.htm"
"Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions",2012-12-19,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332860.htm"
"Infants’ TYLENOL Oral Suspension, 1 oz. Grape: Recall - Dosing System Complaints",2012-02-17,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm292566.htm"
"Intestinomicina (contains chloramphenicol) by Laboratorios Lopez: Safety Alert - Contains Drug Ingredient Withdrawn from US",2012-09-18,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm319905.htm"
"Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw",2012-06-06,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm307103.htm"
"Isovue (iopamidol injection) Pre-Filled Power Injector Syringes by Bracco Diagnostics Inc.: Recall - Presence of Particulates",2012-11-28,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm329948.htm"
"Leucovorin Calcium Injection (Bedford Laboratories): Recall - Visible Particulate Matter",2012-07-06,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm310782.htm"
"Lo/Ovral-28 (Norgestrel/EthinylEstradiol) Tablets: Recall - Possibility of Inexact Tablet Counts or Out of Sequence Tablets",2012-02-01,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm289803.htm"
"Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure",2012-09-19,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm320054.htm"
"Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume",2012-04-18,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm300852.htm"
"Fungal Meningitis Outbreak",2012-11-01,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm323946.htm"
"New England Compounding Center (NECC) Potentially Contaminated Medication: Fungal Meningitis Outbreak",2012-10-06,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm322849.htm"
"Nimodipine: Recall - Crystallization of Fill Material",2012-09-05,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm318207.htm"
"Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen",2012-02-27,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm293385.htm"
"Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps",2012-01-09,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm286265.htm"
"Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to  Potential For Serious Cardiac Risks",2012-12-04,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm330772.htm"
"Over-The-Counter Eye Drops and Nasal Sprays: Drug Safety Communication - Serious Adverse Events From Accidental Ingestion by Children",2012-10-25,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm325729.htm"
"Over-The-Counter Topical Muscle and Joint Pain Relievers: Drug Safety Communication - Rare Cases of Serious Burns",2012-09-13,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm319353.htm"
"Perfect Image Solutions Topical Hair Regrowth Products: Recall - Unapproved Drugs, Risk of Health Hazards",2012-01-20,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm288562.htm"
"Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events 					[ARCHIVED]",2012-11-02,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm282820.htm"
"Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves",2012-12-19,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332949.htm"
"Proton Pump Inhibitors (PPIs) - Drug Safety Communication: Clostridium Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs",2012-02-08,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm290838.htm"
"Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets",2012-12-21,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm331224.htm"
"Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall -  Potential for Oversized Tablets",2012-09-11,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm319058.htm"
"Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children",2012-08-30,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm317743.htm"
"Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies 					[ARCHIVED]",2012-05-07,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm250606.htm"
"SimplyThick: Public Health Notification - Risk of Life-Threatening Bowel Condition 					[ARCHIVED]",2012-09-18,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm256257.htm"
"Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury",2012-03-15,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm296261.htm"
"Statins and HIV or Hepatitis C Drugs: Drug  Safety Communication -  Interaction Increases Risk of Muscle Injury",2012-03-01,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm294294.htm"
"Statin Drugs - Drug Safety Communication: Class Labeling Change",2012-02-28,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm293670.htm"
"Teva’s Adderall 30 mg Tablets: Counterfeit Product - Contains Wrong Active Ingredients",2012-05-30,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm306041.htm"
"Treanda (bendamustine HCL): Recall - Particulate Matter in Vial",2012-01-30,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm289521.htm"
"Tysabri (natalizumab): Drug Safety Communication - New Risk Factor for Progressive Multifocal Leukoencephalopathy (PML)",2012-01-20,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm288602.htm"
"Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter",2012-06-29,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm310210.htm"
"Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions",2012-04-26,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm291144.htm"
"Wholistic Herbs, Inc. ""Koff and Kold"" and ""Kold Sore"" Spray: Recall - Non-Sterile Products",2012-02-10,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm291534.htm"
"Xyrem (sodium oxybate): Drug Safety Communication - Warning Against Use With Alcohol or Drugs Causing Respiratory Depression",2012-12-17,"http://wayback.archive-it.org/7993/20170111132914/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm332430.htm"
"5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer 					[ARCHIVED]",2011-06-09,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258529.htm"
"Abacavir - Ongoing Safety Review: Possible Increased Risk of Heart Attack 					[ARCHIVED]",2011-03-01,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245190.htm"
"Acetadote (acetylcysteine) Injection: Recall - Particulate Matter Found in a Small Number of Vials 					[ARCHIVED]",2011-01-01,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm238494.htm"
"Acetaminophen Prescription Products Limited to 325 mg Per Dosage Unit: Drug Safety Communication 					[ARCHIVED]",2011-01-13,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm239955.htm"
"Aidapak Services Repackaged Pharmaceuticals: Recall - Potential Cross Contamination with Beta Lactam Products 					[ARCHIVED]",2011-06-03,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm257723.htm"
"Albuterol Sulfate Inhalation Solution 0.083%, 3 mL Unit Dose Vials: Recall - Mislabeled Unit Dose Vials 					[ARCHIVED]",2011-01-03,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm238624.htm"
"American Regent Injectable Products: Recall - Visible Particulates in Products 					[ARCHIVED]",2012-02-23,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm242365.htm"
"Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed 					[ARCHIVED]",2011-06-02,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm219185.htm"
"Antipsychotic drugs: Class Labeling Change - Treatment During Pregnancy and Potential Risk to Newborns 					[ARCHIVED]",2011-02-22,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm244175.htm"
"Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events 					[ARCHIVED]",2011-11-04,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226994.htm"
"Benzocaine Topical Products: Sprays, Gels and Liquids - Risk of Methemoglobinemia 					[ARCHIVED]",2011-04-07,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm250264.htm"
"Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots 					[ARCHIVED]",2011-10-27,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm257337.htm"
"Butalbital, Acetaminophen, and Caffeine Tablets (USP 50mg, 325mg, 40mg) and Hydrocodone Bitartrate and Acetaminophen Tablets (USP 7.5mg, 500mg): Recall - Bottle Mislabeled 					[ARCHIVED]",2011-06-27,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm260915.htm"
"CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure 					[ARCHIVED]",2012-01-12,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm263157.htm"
"Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses 					[ARCHIVED]",2011-08-24,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm269481.htm"
"Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events 					[ARCHIVED]",2011-07-22,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm259469.htm"
"Citalopram And Finasteride by Greenstone:  Recall - Possible Mislabeling 					[ARCHIVED]",2011-03-28,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm248595.htm"
"Coumadin (warfarin sodium) Crystalline 5 mg Tablets: Recall - Tablets May Have Higher than Expected Potency 					[ARCHIVED]",2011-05-03,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm253615.htm"
"Diflucan (fluconazole): Drug Safety Communication – Long-term, High-dose Use During Pregnancy May Be Associated With Birth Defects 					[ARCHIVED]",2011-08-03,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm266468.htm"
"Endocet (Oxycodone / Acetaminophen) Tablets,  ( 10mg, 325mg ) : Recall - Some Bottles Contain Different Strength Tablets 					[ARCHIVED]",2011-06-27,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm260979.htm"
"Erythropoiesis-Stimulating Agents (ESAs) In Chronic Kidney Disease: Drug Safety Communication - Modified Dosing Recommendations 					[ARCHIVED]",2011-06-24,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm260641.htm"
"Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose 					[ARCHIVED]",2012-05-14,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm284355.htm"
"H & P Industries Povidone Iodine Swabsticks, Prep Solutions, Scrub Solutions, and Prep Gel: Recall - Inadequate Microbial Testing 					[ARCHIVED]",2012-09-25,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm269800.htm"
"H & P Industries Povidone Iodine Prep Pads: Recall - Potential Microbial Contamination 					[ARCHIVED]",2012-02-08,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm247743.htm"
"Hydrocodone Bitartrate And Acetaminophen Tablets, Phenobarbital Tablets by Qualitest: Recall - Incorrect Package Labeling 					[ARCHIVED]",2011-02-07,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm242527.htm"
"Indomethacin for Injection: Recall of One Lot - Particulate Matter 					[ARCHIVED]",2011-06-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm259262.htm"
"Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant 					[ARCHIVED]",2011-03-28,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm248598.htm"
"Kaletra (lopinavir/ritonavir): Label Change - Serious Health Problems in Premature Babies 					[ARCHIVED]",2011-03-08,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm246167.htm"
"Liquid Acetaminophen marketed for infants: Drug Safety Communication - Potential for Dosing Errors 					[ARCHIVED]",2011-12-22,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm284807.htm"
"Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals - Clogged, Blocked Oral Syringes and Feeding Tubes 					[ARCHIVED]",2011-04-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251575.htm"
"Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements 					[ARCHIVED]",2011-04-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201003.htm"
"Meds IV Pharmacy, IV Compounded Products Recall: Outbreak of Serratia Marcescens Bacteremia in Alabama Hospitals 					[ARCHIVED]",2011-03-30,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm249099.htm"
"Methylene Blue: Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications 					[ARCHIVED]",2011-10-21,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm265476.htm"
"Metronidazole Tablets, 250mg: Recall - Underweight Tablets 					[ARCHIVED]",2011-01-06,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm239312.htm"
"Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL): Medication Use Error - Reports of Accidental Overdose 					[ARCHIVED]",2011-01-10,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm239559.htm"
"Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events 					[ARCHIVED]",2011-12-19,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm264204.htm"
"Multaq (dronedarone) - Drug Safety Communication: Risk of Severe Liver Injury 					[ARCHIVED]",2011-01-14,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm240110.htm"
"Nature Relief Instant Wart and Mole Remover: Recall - Risk of Severe Skin Burns 					[ARCHIVED]",2011-06-27,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm260982.htm"
"Needleless Pre-filled Glass Syringes: Stakeholder Advisory - Compatibility Problems with Needleless Intravenous Access Systems 					[ARCHIVED]",2011-05-06,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm234219.htm"
"Nostrilla Nasal Decongestant: Recall - Bacterial Contamination 					[ARCHIVED]",2011-10-21,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm276771.htm"
"Nulojix (belatacept): Risk Evaluation and Mitigation Strategy (REMS) 					[ARCHIVED]",2011-07-07,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm262210.htm"
"Ondansetron (Zofran) IV: Drug Safety Communication - QT prolongation 					[ARCHIVED]",2012-06-29,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm310219.htm"
"Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal   Cancer 					[ARCHIVED]",2011-07-21,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm264087.htm"
"Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events 					[ARCHIVED]",2012-11-02,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm282820.htm"
"Pradaxa (dabigatran etexilate mesylate) Capsules: Special Storage and Handling Requirements 					[ARCHIVED]",2011-03-30,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm249005.htm"
"Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication - Low Magnesium Levels Can Be Associated With Long-Term Use 					[ARCHIVED]",2011-03-02,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245275.htm"
"Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error 					[ARCHIVED]",2011-09-16,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm272237.htm"
"Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment 					[ARCHIVED]",2011-09-01,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm270464.htm"
"Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies 					[ARCHIVED]",2012-05-07,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm250606.htm"
"Risperdal (risperidone) and Risperidone: Recall - Uncharacteristic Odor 					[ARCHIVED]",2011-06-20,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm259901.htm"
"Risperidone (Risperdal) and Ropinirole (Requip): Medication Errors - Name Confusion 					[ARCHIVED]",2011-06-13,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258905.htm"
"Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions 					[ARCHIVED]",2011-09-01,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm270600.htm"
"Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication -  Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn 					[ARCHIVED]",2011-12-14,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm283696.htm"
"Sprycel (dasatinib): Drug Safety Communication - Risk of Pulmonary Arterial Hypertension 					[ARCHIVED]",2011-10-11,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm275176.htm"
"Tamiflu (oseltamivir phosphate) for Oral Suspension: Label Change-New Concentration (6 mg/mL) 					[ARCHIVED]",2011-07-11,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm262432.htm"
"Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor 					[ARCHIVED]",2011-02-17,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243843.htm"
"Topamax (topiramate): Recall - Musty Odor 					[ARCHIVED]",2011-04-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251556.htm"
"Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns 					[ARCHIVED]",2011-03-04,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245777.htm"
"Triad Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks: Recall Due to Potential Microbial Contamination 					[ARCHIVED]",2011-06-08,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm239319.htm"
"Trilipix (fenofibric acid): Drug Safety Communication - Label Change 					[ARCHIVED]",2011-11-09,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm279185.htm"
"Tumor Necrosis Factor-alpha (TNFα) Blockers: Label Change - Boxed Warning Updated for Risk of Infection from Legionella and Listeria 					[ARCHIVED]",2011-09-07,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm270977.htm"
"Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Update on Reports of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults 					[ARCHIVED]",2011-11-04,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm251443.htm"
"Tylenol Extra Strength Caplets, 225 count bottles: Recall - Uncharacteristic Odor 					[ARCHIVED]",2011-06-29,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm261509.htm"
"Tysabri (natalizumab): Update of Healthcare Professional Information 					[ARCHIVED]",2011-04-22,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm199965.htm"
"Unapproved Cough, Cold, Allergy Products: FDA Prompts Removal From Market 					[ARCHIVED]",2011-03-02,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm245279.htm"
"Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage 					[ARCHIVED]",2011-02-21,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243850.htm"
"Yervoy (ipilimumab): Risk Evaluation and Mitigation Strategy (REMS) - Severe Immune-Mediated Adverse Reactions 					[ARCHIVED]",2011-04-06,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm249770.htm"
"Valproate Products: Drug Safety Communication - Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy) 					[ARCHIVED]",2011-06-30,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm261610.htm"
"Vasopressin Injection USP, Multiple Dose Vials: Recall - Sub-Potency 					[ARCHIVED]",2011-08-04,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm266648.htm"
"Victoza (liraglutide [rDNA origin]) Injection: REMS - Risk of Thyroid C-cell Tumors, Acute Pancreatitis 					[ARCHIVED]",2011-06-13,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm"
"Xigris [drotrecogin alfa (activated)]: Market Withdrawal - Failure to Show Survival Benefit 					[ARCHIVED]",2011-10-25,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm277143.htm"
"Zocor (simvastatin): Label Change - New Restrictions, Contraindications, and Dose Limitations 					[ARCHIVED]",2011-12-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258384.htm"
"Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms 					[ARCHIVED]",2011-09-15,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm272041.htm"
"Zyvox (linezolid): Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications 					[ARCHIVED]",2011-10-21,"http://wayback.archive-it.org/7993/20170111132925/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm265479.htm"
"Actos (pioglitazone): Ongoing Safety Review - Potential Increased Risk of Bladder Cancer",2011-06-15,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226257.htm"
"Advair Diskus (fluticasone propionate and salmeterol inhalation powder): Stolen Product Warning 					[ARCHIVED]",2010-07-16,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm219416.htm"
"Alli 60 mg capsules (120 count refill kit): Counterfeit Product 					[ARCHIVED]",2010-01-23,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm197862.htm"
"Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed 					[ARCHIVED]",2011-06-02,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm219185.htm"
"Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms 					[ARCHIVED]",2010-12-17,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm237341.htm"
"Arava (leflunomide): Boxed Warning - Risk of Severe Liver Injury 					[ARCHIVED]",2010-07-13,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm218912.htm"
"Aromatase Inhibitors in Products Marketed as Dietary Supplements: Recall 					[ARCHIVED]",2010-10-08,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226343.htm"
"Arrow Brand Medicated Oil and Embrocation: Consumer Warning, Product Considered Toxic 					[ARCHIVED]",2010-05-28,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213738.htm"
"Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events 					[ARCHIVED]",2011-11-04,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm226994.htm"
"Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety 					[ARCHIVED]",2010-02-22,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201446.htm"
"Avastin (bevacizumab): Process for Removal of Breast Cancer Indication Begun 					[ARCHIVED]",2010-12-16,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm237280.htm"
"Benadryl Extra Strength Itch Stopping Gel: Packaging Changes to Reduce Use Errors 					[ARCHIVED]",2010-05-12,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm211792.htm"
"Benicar (olmesartan): Ongoing Safety Review",2011-04-14,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm215249.htm"
"Bisphosphonates (Osteoporosis Drugs): Label Change - Atypical Fractures Update 					[ARCHIVED]",2010-10-13,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm229244.htm"
"Camolyn eye drops, Fisiolin nasal drops: Voluntary recall due to non-sterility 					[ARCHIVED]",2010-04-07,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm207794.htm"
"Chelation Products: Unapproved Over-the-Counter Drugs - Consumer Warning 					[ARCHIVED]",2010-10-14,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm229454.htm"
"Coumadin 1 mg Tablet Blister Packs: Recall 					[ARCHIVED]",2010-07-14,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm218955.htm"
"Cubicin (daptomycin): Drug Safety Communication -  Risk of  Eosinophilic Pneumonia 					[ARCHIVED]",2010-07-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm220499.htm"
"Dexamethasone Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose Vial: Recall due to Particulates in Product 					[ARCHIVED]",2010-12-24,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm238104.htm"
"Epogen and Procrit (epoetin alfa): Recall - Particulate Matter in Vials 					[ARCHIVED]",2010-09-24,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm227225.htm"
"Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication 					[ARCHIVED]",2010-02-16,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm200391.htm"
"Evamist (estradiol transdermal spray): Drug Safety Communication - Unintended Exposure of Children and Pets to Topical Estrogen 					[ARCHIVED]",2010-07-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm220548.htm"
"Exjade (deferasirox): Boxed Warning 					[ARCHIVED]",2010-02-18,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm200850.htm"
"Fentanyl Transdermal System: Recall - Potential for Active Ingredient to Release Faster Than Specified 					[ARCHIVED]",2010-11-05,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230639.htm"
"Gadolinium-based Contrast Agents: Class Labeling Change - Risk of Nephrogenic Systemic Fibrosis 					[ARCHIVED]",2010-09-09,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225375.htm"
"GnRH Agonists: Label Change - Increased Risk of Diabetes and Cardiovascular Disease (Update) 					[ARCHIVED]",2010-10-20,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230359.htm"
"GnRH Agonists:  Safety Review of Drug Class Used to Treat Prostate Cancer 					[ARCHIVED]",2010-05-03,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm210576.htm"
"Heparin Sodium (B. Braun): Recall - Trace Contaminant 					[ARCHIVED]",2010-10-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm231739.htm"
"Heparin: Change in Reference Standard 					[ARCHIVED]",2010-04-07,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm184687.htm"
"Hospira Brand Liposyn and Propofol: Recall 					[ARCHIVED]",2010-06-10,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm215033.htm"
"Hyland’s Teething Tablets: Recall - Risk of Harm to Children 					[ARCHIVED]",2010-10-24,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230764.htm"
"Hylenex recombinant (hyaluronidase human injection): Recall 					[ARCHIVED]",2010-05-26,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213532.htm"
"Intravenous Medications Manufactured by Claris: Recall due to contamination of products 					[ARCHIVED]",2010-05-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm214034.htm"
"Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm 					[ARCHIVED]",2010-10-21,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230449.htm"
"Invirase (saquinavir): Ongoing safety review of clinical trial data 					[ARCHIVED]",2010-02-23,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201563.htm"
"Lamictal (lamotrigine): Label Change - Risk of Aseptic Meningitis 					[ARCHIVED]",2010-08-12,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm222269.htm"
"Lipitor (atorvastatin) 40 mg: Recall Specific Bottles 					[ARCHIVED]",2010-12-23,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm229006.htm"
"Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements 					[ARCHIVED]",2011-04-15,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201003.htm"
"Maalox Total Relief and Maalox Liquid Products: Medication Use Errors 					[ARCHIVED]",2010-02-17,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm200672.htm"
"McNeil Consumer Healthcare Over-the-Counter Infants’ and Children’s Products: Recall 					[ARCHIVED]",2010-04-30,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm210442.htm"
"McNeil Consumer Healthcare Over-The-Counter Products: Recall 					[ARCHIVED]",2010-07-08,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm197740.htm"
"Meridia (sibutramine): Market Withdrawal Due to Risk of Serious Cardiovascular Events 					[ARCHIVED]",2010-10-08,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm228830.htm"
"Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review 					[ARCHIVED]",2010-01-21,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm198221.htm"
"Methotrexate Injection, 50mg/2mL and 250mg/10mL Vials: Recall - Presence of Glass Particulates 					[ARCHIVED]",2010-10-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm231614.htm"
"Metronidazole injection 500 mg / 100 ml: Voluntary recall due to non-sterility 					[ARCHIVED]",2010-05-17,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm212311.htm"
"Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug 					[ARCHIVED]",2010-08-16,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm222640.htm"
"Mylotarg (gemtuzumab ozogamicin): Market Withdrawal 					[ARCHIVED]",2010-06-21,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm"
"Needleless Pre-filled Glass Syringes: Stakeholder Advisory - Compatibility Problems with Needleless Intravenous Access Systems 					[ARCHIVED]",2011-05-06,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm234219.htm"
"NeoProfen (ibuprofen lysine) Injection: Recall and Shortage - Risk of Particulate Matter 					[ARCHIVED]",2010-08-02,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm220798.htm"
"Nimodipine Oral Capsules: Medication Errors - IV Administration May Result in Death, Serious Harms 					[ARCHIVED]",2010-08-02,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm220840.htm"
"Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures 					[ARCHIVED]",2010-03-11,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm204127.htm"
"Orlistat (marketed as Alli and Xenical): Labeling Change 					[ARCHIVED]",2010-05-26,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213448.htm"
"PediaCare Children's Products [Blacksmith Brand]: Recall of four products 					[ARCHIVED]",2010-05-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm214036.htm"
"Plavix (clopidogrel): Reduced effectiveness in patients who are poor metabolizers of the drug 					[ARCHIVED]",2010-03-12,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm204256.htm"
"Promacta (eltrombopag):  Portal Venous System Thromboses in Study of Patients With Chronic Liver Disease 					[ARCHIVED]",2010-05-12,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm211796.htm"
"Propoxyphene: Withdrawal - Risk of Cardiac Toxicity 					[ARCHIVED]",2010-11-19,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm234389.htm"
"Propylthiouracil 					[ARCHIVED]",2010-04-21,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm164162.htm"
"Proton Pump Inhibitors (PPI): Class Labeling Change",2010-05-25,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213321.htm"
"Qualaquin (quinine sulfate): New Risk Evaluation and Mitigation Strategy - Risk of serious hematological reactions",2010-08-04,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm218424.htm"
"Rapamune (sirolimus): Drug Monitoring Recommendations",2010-01-11,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm197059.htm"
"Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death",2011-08-04,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm237969.htm"
"Reese Pharmaceutical Company OTC Products: Recall -  Mislabeled Guaifenesin Tablets 					[ARCHIVED]",2010-12-13,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm236593.htm"
"Rolaids Extra Strength Softchews, Rolaids Extra Strength plus Gas Softchews, Rolaids Multi-Symptom plus Anti-Gas Softchews: Recall - Foreign Materials in Products 					[ARCHIVED]",2010-12-14,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm236907.htm"
"Sodium Bicarbonate Injection, USP, 7.5% and 8.4%, 50 mL Single Dose Vials  - Recall Due to Particulates in Some Vials 					[ARCHIVED]",2010-12-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm238323.htm"
"Stalevo (entacapone/carbidopa/levodopa): Ongoing Safety Review 					[ARCHIVED]",2010-03-31,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm206934.htm"
"Stalevo(carbidopa/levodopa and entacapone): Ongoing Safety Review: Possible increased cardiovascular risk 					[ARCHIVED]",2010-08-20,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm223423.htm"
"Tamiflu: Counterfeit Product Sold on Internet 					[ARCHIVED]",2010-06-17,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216183.htm"
"Tessalon (benzonatate): Drug Safety Communication - Potential for Accidental Ingestion by Children 					[ARCHIVED]",2010-12-14,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm236928.htm"
"Tygacil (tigecycline): Label Change - Increased Mortality Risk 					[ARCHIVED]",2010-09-01,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm224626.htm"
"Tylenol 8 Hour Caplets 50 Count: Recall 					[ARCHIVED]",2010-10-19,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm230218.htm"
"Tysabri (natalizumab): Update of Healthcare Professional Information 					[ARCHIVED]",2011-04-22,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm199965.htm"
"Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label Change 					[ARCHIVED]",2010-05-25,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213264.htm"
"Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients 					[ARCHIVED]",2010-09-15,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm225888.htm"
"Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment 					[ARCHIVED]",2010-01-26,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm198424.htm"
"Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension 					[ARCHIVED]",2010-01-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm199343.htm"
"Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients 					[ARCHIVED]",2010-05-04,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm210755.htm"
"Zocor (simvastatin): increased risk of muscle injury with high doses 					[ARCHIVED]",2010-03-19,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm205404.htm"
"Zyprexa (olanzapine): Use in Adolescents 					[ARCHIVED]",2010-01-29,"http://wayback.archive-it.org/7993/20170111132935/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm198402.htm"
"Albuterol Sulfate Inhalation Solution unit-dose vials (Dey LP brand) 					[ARCHIVED]",2009-09-10,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm181772.htm"
"Alka-Seltzer Plus Day & Night Cold Formula Liquid Gels - Incorrect Packaging 					[ARCHIVED]",2009-12-09,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193583.htm"
"Atlas Operations, Inc.: Recall of Sexual Enhancement Products 					[ARCHIVED]",2010-04-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm194091.htm"
"Dietary Supplements Sold on Internet by Bodybuilding.com 					[ARCHIVED]",2009-11-03,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188957.htm"
"Body Building Products (Marketed as Containing Steroids or Steroid-like Substances) 					[ARCHIVED]",2009-07-28,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173983.htm"
"Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) 					[ARCHIVED]",2009-04-30,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm164255.htm"
"Byetta (exenatide) - Renal Failure 					[ARCHIVED]",2009-11-02,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm188703.htm"
"Cefepime (marketed as Maxipime) Update of Ongoing Safety Review 					[ARCHIVED]",2009-06-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm167427.htm"
"Ceftriaxone (marketed as Rocephin and generics) 					[ARCHIVED]",2009-04-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm136533.htm"
"CellCept (mycophenolate mofetil) August 2009 					[ARCHIVED]",2009-08-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm177397.htm"
"CellCept (mycophenolate mofetil) and Myfortic (mycophenolic acid) 					[ARCHIVED]",2009-02-12,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092157.htm"
"Children's and Infants' Tylenol Oral Suspension Products - Recall 					[ARCHIVED]",2009-09-25,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183924.htm"
"Cleviprex (clevidipine butyrate): Recall 					[ARCHIVED]",2010-03-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm194585.htm"
"Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction 					[ARCHIVED]",2009-11-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190848.htm"
"Clopidogrel bisulfate (marketed as Plavix) 					[ARCHIVED]",2009-01-26,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092066.htm"
"Colchicine (marketed as Colcrys) 					[ARCHIVED]",2009-07-30,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm174596.htm"
"Concentrated Acetaminophen Drops 					[ARCHIVED]",2009-07-15,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172252.htm"
"Dexferrum (iron dextran injection) - Labeling Change 					[ARCHIVED]",2009-10-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm186899.htm"
"Dextroamphetamine, Amphetamine 20mg Tablets 					[ARCHIVED]",2009-08-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm177434.htm"
"Dietary Supplements Distributed by Universal ABC Beauty Supply International, Inc. 					[ARCHIVED]",2009-04-22,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm142279.htm"
"Digoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand) 					[ARCHIVED]",2009-05-12,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm128096.htm"
"Ethex Corporation Product Recall 					[ARCHIVED]",2009-01-27,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092072.htm"
"Exjade (deferasirox) - Early Communication 					[ARCHIVED]",2009-09-25,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183840.htm"
"Genzyme  Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen 					[ARCHIVED]",2009-11-13,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190480.htm"
"Heparin: Change in Reference Standard 					[ARCHIVED]",2010-04-07,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm184687.htm"
"Hospira Brand Propofol and Liposyn Products - Recall 					[ARCHIVED]",2009-11-09,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm189589.htm"
"Ibuprofen (Unapproved) topical drug products 					[ARCHIVED]",2009-08-21,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm179925.htm"
"IDS Sports Dietary Supplements - Recall 					[ARCHIVED]",2009-11-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190925.htm"
"Immunosuppressant Drugs: Required Labeling Changes 					[ARCHIVED]",2009-07-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171828.htm"
"Influend Cough and Cold Products 					[ARCHIVED]",2009-04-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm136536.htm"
"Insulin Pens: Risk of Transmission of Blood-borne Pathogens from Shared Use 					[ARCHIVED]",2009-03-19,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm127783.htm"
"Intelence (etravirine) 					[ARCHIVED]",2009-08-27,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm180579.htm"
"Ketorolac Tromethamine Injection, USP 30 mg/mL; 1mL and 2mL Single Dose Vials -- Recall 					[ARCHIVED]",2009-11-03,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm187481.htm"
"Lantus (insulin glargine) 					[ARCHIVED]",2009-07-01,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm170089.htm"
"Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR) 					[ARCHIVED]",2009-08-28,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166246.htm"
"Levemir Insulin (Novo Nordisk) 					[ARCHIVED]",2009-08-26,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166359.htm"
"Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter 					[ARCHIVED]",2009-12-03,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm192699.htm"
"Libimax 					[ARCHIVED]",2009-04-29,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm143820.htm"
"Libipower Plus 					[ARCHIVED]",2009-07-14,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171914.htm"
"Local Anesthetics, Continuously Infused (marketed as bupivacaine, chlorprocaine, lidocaine, mepivacaine, procaine, ropivacaine) - Chondrolysis 					[ARCHIVED]",2009-11-13,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190496.htm"
"Mallinckrodt Sodium Chromate Cr-51 Injection 					[ARCHIVED]",2009-07-10,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm171396.htm"
"Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review 					[ARCHIVED]",2009-11-20,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm191655.htm"
"Metoclopramide-Containing Drugs 					[ARCHIVED]",2009-02-26,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm106942.htm"
"Myfortic (mycophenolic acid) 					[ARCHIVED]",2009-09-03,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm181306.htm"
"Natalizumab (marketed as Tysabri) 					[ARCHIVED]",2009-09-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm182667.htm"
"Nature & Health Co. supplement products: LibieXtreme, Y-4ever, Libimax X Liquid, Powermania Liquid and Capsule, Herbal Disiac 					[ARCHIVED]",2009-07-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172312.htm"
"Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter 					[ARCHIVED]",2009-12-02,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm192655.htm"
"Omalizumab (marketed as Xolair) - Early Communication about an Ongoing Safety Review 					[ARCHIVED]",2009-07-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172406.htm"
"Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review 					[ARCHIVED]",2009-08-24,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm180025.htm"
"Pai You Guo, Marketed as Dietary Supplement - Recall 					[ARCHIVED]",2009-11-13,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm190531.htm"
"Peramivir IV 					[ARCHIVED]",2009-10-24,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm187814.htm"
"Promethazine Hydrochloride Injection 					[ARCHIVED]",2009-09-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm182500.htm"
"Propafenone HCL Tablets 					[ARCHIVED]",2009-03-25,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm127790.htm"
"Propofol Injectable Emulsion, 10 mg/mL 100 mL vials 					[ARCHIVED]",2009-07-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172507.htm"
"Propoxyphene-containing Products 					[ARCHIVED]",2009-07-07,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm170763.htm"
"Propylthiouracil 					[ARCHIVED]",2010-04-21,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm164162.htm"
"Raptiva (efalizumab) Feb 2009 					[ARCHIVED]",2009-02-19,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm149675.htm"
"Relenza (zanamivir) Inhalation Powder 					[ARCHIVED]",2009-10-09,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm186081.htm"
"Rituxan (rituximab) - PML 					[ARCHIVED]",2009-10-23,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm187791.htm"
"RockHard Weekend - product contains undeclared drug ingredient 					[ARCHIVED]",2009-11-18,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm191052.htm"
"Simponi (golimumab) 					[ARCHIVED]",2009-05-28,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm162802.htm"
"Sirolimus (marketed as Rapamune) 					[ARCHIVED]",2009-06-11,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm165731.htm"
"Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis 					[ARCHIVED]",2009-09-25,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm"
"Skin Products Made by Clarcon 					[ARCHIVED]",2009-06-09,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm165028.htm"
"Stamina-Rx Dietary Supplement Products 					[ARCHIVED]",2009-06-19,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm168017.htm"
"Stiff Nights - product contains undeclared drug ingredient 					[ARCHIVED]",2009-11-05,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm189300.htm"
"Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder - Communication about an Ongoing Safety Review 					[ARCHIVED]",2009-12-12,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166667.htm"
"Steam Dietary Supplement 					[ARCHIVED]",2009-08-24,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm174339.htm"
"Tamiflu (oseltamivir) for Oral Suspension 					[ARCHIVED]",2009-10-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183714.htm"
"Tarceva (erlotinib) May 2009 					[ARCHIVED]",2009-05-08,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm150596.htm"
"Testosterone gel products (AndroGel 1% and Testim 1% ) 					[ARCHIVED]",2009-05-07,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm149346.htm"
"Topical Anesthetics 					[ARCHIVED]",2009-01-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092082.htm"
"Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) August 2009 					[ARCHIVED]",2009-08-31,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm175843.htm"
"Tylenol Arthritis Pain Caplet, 100 count bottles: Recall of all lots 					[ARCHIVED]",2010-01-15,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm195704.htm"
"Valproate Sodium and related products (valproic acid and divalproex sodium): Risk of Birth Defects 					[ARCHIVED]",2009-12-03,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm192788.htm"
"Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics) 					[ARCHIVED]",2009-07-01,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm170090.htm"
"Venom HYPERDRIVE 3.0 					[ARCHIVED]",2009-01-27,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092095.htm"
"Vicks Sinex Nasal Spray - Recall 					[ARCHIVED]",2009-11-19,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm191413.htm"
"Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes 					[ARCHIVED]",2009-12-04,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193047.htm"
"Weight Loss Products by Young You Corporation 					[ARCHIVED]",2009-07-17,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172527.htm"
"Xigris (Drotrecogin alfa [activated]) - Early Communication about an Ongoing Safety Review 					[ARCHIVED]",2009-02-04,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm092099.htm"
"Zencore Plus 					[ARCHIVED]",2009-03-20,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm127785.htm"
"Zicam Cold Remedy Nasal Products (Cold Remedy Nasal Gel, Cold Remedy Nasal Swabs, and  Cold Remedy Swabs, Kids Size) 					[ARCHIVED]",2009-06-16,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166996.htm"
"Zonisamide (marketed as Zonegran, and generics) 					[ARCHIVED]",2009-02-23,"http://wayback.archive-it.org/7993/20170111132947/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm106934.htm"
"Abilify (aripiprazole) 					[ARCHIVED]",2004-04-12,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153025.htm"
"Amaryl (glimepiride) 					[ARCHIVED]",2004-10-26,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153090.htm"
"American Health Herbs Ministry Eye Rinse Products 					[ARCHIVED]",2004-12-29,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153097.htm"
"Bextra  (valdecoxib) 					[ARCHIVED]",2004-12-10,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153099.htm"
"Bicillin C-R (penicillin G benzathine and penicillin G procaine injectable suspension) 					[ARCHIVED]",2004-11-30,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153100.htm"
"Bicillin L-A (penicillin G benzathine injectable suspension) 					[ARCHIVED]",2004-11-30,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm153348.htm"
"Carbolith (lithium carbonate) 					[ARCHIVED]",2004-12-09,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154050.htm"
"Celebrex (celecoxib) Dec 2004 					[ARCHIVED]",2004-12-21,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166124.htm"
"Children's Motrin Grape Chewable Tablets 					[ARCHIVED]",2004-05-14,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154086.htm"
"Clozaril (clozapine tablets) 					[ARCHIVED]",2004-04-07,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154110.htm"
"Counterfeit contraceptive patches 					[ARCHIVED]",2004-02-06,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154129.htm"
"Crestor (rosuvastatin) Jun 2004 					[ARCHIVED]",2004-06-09,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166321.htm"
"Cytotec Solutions, Inc. Products 					[ARCHIVED]",2004-04-15,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154780.htm"
"Depo-Provera (medroxyprogesterone acetate injectable suspension) 					[ARCHIVED]",2004-11-19,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154784.htm"
"Desyrel (trazodone hydrochloride) 					[ARCHIVED]",2004-05-12,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154912.htm"
"Domperidone 					[ARCHIVED]",2004-06-10,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154914.htm"
"Duragesic (fentanyl transdermal system) Feb 2004 					[ARCHIVED]",2004-02-20,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166410.htm"
"Effexor and Effexor XR (venlafaxine HCl) 					[ARCHIVED]",2004-06-28,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154975.htm"
"Geodon (ziprasidone) 					[ARCHIVED]",2004-08-31,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154977.htm"
"Levoxyl (levothyroxine sodium) 					[ARCHIVED]",2004-10-04,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm154979.htm"
"Lovenox (enoxaparin sodium injection) 					[ARCHIVED]",2004-08-17,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155077.htm"
"Major Twice-A-Day 12 Hour Nasal Spray 					[ARCHIVED]",2004-03-26,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155078.htm"
"Mifeprex (mifepristone) Nov 2004 					[ARCHIVED]",2004-11-15,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166463.htm"
"Naproxen 					[ARCHIVED]",2004-12-21,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155478.htm"
"Oral-B CrossAction Power and PowerMAX Toothbrushes and Refills 					[ARCHIVED]",2004-10-29,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155479.htm"
"OTC pain and fever reducers (acetaminophen / NSAIDs) 					[ARCHIVED]",2004-01-22,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155483.htm"
"Oxandrin (oxandrolone, USP) 					[ARCHIVED]",2004-05-05,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155484.htm"
"Paxil (paroxetine hydrochloride) 					[ARCHIVED]",2004-06-22,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155485.htm"
"Protonix I.V. (pantoprazole sodium) 					[ARCHIVED]",2004-09-24,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155487.htm"
"Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Anti-depressant Medications 					[ARCHIVED]",2004-10-15,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155488.htm"
"Public Health Advisory: Antidepressant Use in Children, Adolescents, and Adults 					[ARCHIVED]",2004-03-22,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155489.htm"
"Public Health Advisory: FDA Recommendations Concerning the Use of NSAIDs 					[ARCHIVED]",2004-12-27,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155491.htm"
"Remicade (infliximab) 					[ARCHIVED]",2004-10-13,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155493.htm"
"Reminyl (galantamine hydrobromide) Oct 2004 					[ARCHIVED]",2004-10-26,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166516.htm"
"Risperdal (risperidone) Aug 2004 					[ARCHIVED]",2004-08-04,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166517.htm"
"Rituxan (rituximab) Oct 2004 					[ARCHIVED]",2004-10-08,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166521.htm"
"Seroquel  (quetiapine fumarate) 					[ARCHIVED]",2004-04-08,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155495.htm"
"Serzone (nefazodone hydrochloride) 					[ARCHIVED]",2004-06-23,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155496.htm"
"Strattera (atomoxetine) Dec 2004 					[ARCHIVED]",2004-12-21,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166531.htm"
"Vioxx (rofecoxib) Sep 2004 					[ARCHIVED]",2004-09-30,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166532.htm"
"Viramune (nevirapine) Feb 2004 					[ARCHIVED]",2004-02-02,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166533.htm"
"Wellbutrin (bupropion hydrochloride), Wellbutrin SR, Wellbutrin XL 					[ARCHIVED]",2004-06-22,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155510.htm"
"Zelnorm (tegaserod maleate) Apr 2004 					[ARCHIVED]",2004-04-28,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166538.htm"
"Zometa (zoledronic acid) Injection 					[ARCHIVED]",2004-09-30,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155619.htm"
"Zyprexa (olanzapine) Mar 2004 					[ARCHIVED]",2004-03-22,"http://wayback.archive-it.org/7993/20170111133047/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166542.htm"
